Form4insider filings, from the source

SEC Form 4 · accession 0001140361-16-068288

HALOZYME THERAPEUTICS, INC. · HALO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Randal J Kirk
Director · 10% Owner
Period of report
May 31, 2016
Accepted (ET)
Jun 2, 2016 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001159036

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2May 31, 2016J1,326,320—D0Iby NRM IV
Common StockF1,F2May 31, 2016J81,795—A216,795Iby Staff 2001
Common StockF1,F2May 31, 2016J371,186—A3,056,601Iby R.J. Kirk DOT
Common StockF1,F2May 31, 2016J372—A11,317Iby Lotus
Common StockF1,F2May 31, 2016J9,954—A302,954Iby JPK 2008
Common StockF1,F2May 31, 2016J9,954—A302,954Iby MGK 2008
Common StockF1,F2May 31, 2016J9,954—A302,954Iby ZSK 2008
Common StockF1,F2May 31, 2016J23,259—A354,654Iby JPK 2009
Common StockF1,F2May 31, 2016J23,259—A354,653Iby MGK 2009
Common StockF1,F2May 31, 2016J2,235—A2,235Iby ZSK 2009
Common StockF1,F2May 31, 2016J27,260—A290,460Iby JPK 2012
Common StockF1,F2May 31, 2016J4,382—A46,701Iby Kellie L. Banks LTT
Common StockF1,F2May 31, 2016J131,144—A131,144Iby Senior Staff 2006
Common StockF1,F2May 31, 2016J65,572—A65,572Iby Staff 2006
Common StockF1,F2May 31, 2016J21,858—A21,858Iby Incentive 2006
Common StockF2holding———3,977,445Iby Kapital Joe
Common StockF2holding———6,328,853Iby NRM V
Common Stockholding———3,538,253D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses